Healthcare Avoidance by People Who Inject Drugs in Bangkok, Thailand

Overview

Journal J Public Health (Oxf)

Publisher Oxford University Press

Specialty Public Health

Date 2015 Oct 23

PMID 26491067

Citations 20

Authors

A J Heath

T Kerr

L Ti

K Kaplan

P Suwannawong

E Wood

K Hayashi

Affiliations

Soon will be listed here.

Abstract

Background: Although people who inject drugs (IDU) often contend with various health-related harms, timely access to health care among this population remains low. We sought to identify specific individual, social and structural factors constraining healthcare access among IDU in Bangkok, Thailand.

Methods: Data were derived from a community-recruited sample of IDU participating in the Mitsampan Community Research Project between July and October 2011. We assessed the prevalence and correlates of healthcare avoidance due to one's drug use using multivariate logistic regression.

Results: Among 437 participants, 112 (25.6%) reported avoiding health care because they were IDU. In multivariate analyses, factors independently associated with avoiding health care included having ever been drug tested by police [adjusted odds ratio (AOR) = 1.80], experienced verbal abuse (AOR = 3.15), been discouraged from engaging in usual family activities (AOR = 3.27), been refused medical care (AOR = 10.90), experienced any barriers to health care (AOR = 4.87) and received healthcare information and support at a drop-in centre (AOR = 1.92) (all P < 0.05).

Conclusions: These findings highlight the need to address the broader policy environment, which perpetuates the criminalization and stigmatization of IDU, and to expand peer-based interventions to facilitate access to health care for IDU in this setting.

Citing Articles

Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada.

Urbanoski K, van Roode T, Selfridge M, Hogan K, Fraser J, Lock K Subst Abuse Treat Prev Policy. 2024; 19(1):44.

PMID: 39285270 PMC: 11406709. DOI: 10.1186/s13011-024-00625-7.

Efficacy of assisted partner services for people who inject drugs in Kenya to identify partners living with HIV and hepatitis C virus infection: a prospective cohort study.

Monroe-Wise A, Mbogo L, Sambai B, Ludwig-Barron N, Guthrie B, Bukusi D Lancet Glob Health. 2024; 12(5):e859-e867.

PMID: 38614633 PMC: 11097040. DOI: 10.1016/S2214-109X(24)00051-2.

Assessment of HIV viral load monitoring in remote settings in Vietnam - comparing people who inject drugs to the other patients.

Lefrancois L, Nguyen B, Pham T, Le N, Dao H, Tran T PLoS One. 2023; 18(2):e0281857.

PMID: 36802388 PMC: 9942987. DOI: 10.1371/journal.pone.0281857.

The "goldfish bowl": a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting.

Bardwell G, Mansoor M, Van Zwietering A, Cleveland E, Snell D, Kerr T Harm Reduct J. 2022; 19(1):136.

PMID: 36476225 PMC: 9730691. DOI: 10.1186/s12954-022-00725-2.

Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform.

Moallef S, Dale L, Homayra F, Zonneveld C, Milloy M, Nosyk B J Subst Abuse Treat. 2022; 139:108784.

PMID: 35523704 PMC: 9886230. DOI: 10.1016/j.jsat.2022.108784.

References

Nelson P, Mathers B, Cowie B, Hagan H, Des Jarlais D, Horyniak D . Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791):571-83. PMC: 3285467. DOI: 10.1016/S0140-6736(11)61097-0. View

Ti L, Hayashi K, Kaplan K, Suwannawong P, Wood E, Montaner J . HIV test avoidance among people who inject drugs in Thailand. AIDS Behav. 2012; 17(7):2474-8. PMC: 3742418. DOI: 10.1007/s10461-012-0347-2. View

Hayashi K, Suwannawong P, Ti L, Kaplan K, Wood E, Kerr T . High rates of midazolam injection and associated harms in Bangkok, Thailand. Addiction. 2013; 108(5):944-52. DOI: 10.1111/add.12094. View

Hayashi K, Milloy M, Fairbairn N, Kaplan K, Suwannawong P, Lai C . Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand. BMC Public Health. 2010; 9:492. PMC: 2814810. DOI: 10.1186/1471-2458-9-492. View

Newman P, Roungprakhon S, Tepjan S, Yim S, Walisser R . A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand. Glob Public Health. 2012; 7(9):1009-24. DOI: 10.1080/17441692.2012.692388. View

. The Joint United Nations Programme on HIV / AIDS (UNAIDS). Project update. Pac AIDS Alert Bull. 2002; (18):15-6. View

Beyrer C, Jittiwutikarn J, Teokul W, Razak M, Suriyanon V, Srirak N . Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav. 2003; 7(2):153-61. DOI: 10.1023/a:1023946324822. View

Bergenstrom A, Abdul-Quader A . Injection drug use, HIV and the current response in selected low-income and middle-income countries. AIDS. 2010; 24 Suppl 3:S20-9. DOI: 10.1097/01.aids.0000390086.14941.91. View

Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak M . Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg. 2006; 74(6):1111-6. View

10.

Ti L, Hayashi K, Kaplan K, Suwannawong P, Fu E, Wood E . HIV testing and willingness to get HIV testing at a peer-run drop-in centre for people who inject drugs in Bangkok, Thailand. BMC Public Health. 2012; 12:189. PMC: 3337282. DOI: 10.1186/1471-2458-12-189. View

11.

Buavirat A, Page-Shafer K, van Griensven G, Mandel J, Evans J, Chuaratanaphong J . Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 2003; 326(7384):308. PMC: 143525. DOI: 10.1136/bmj.326.7384.308. View

12.

Mathers B, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick R . HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010; 375(9719):1014-28. DOI: 10.1016/S0140-6736(10)60232-2. View

13.

Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J . Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010; 100(8):1449-53. PMC: 2901279. DOI: 10.2105/AJPH.2009.178467. View

14.

Hayashi K, Montaner J, Kaplan K, Suwannawong P, Wood E, Qi J . Low uptake of hepatitis C testing and high prevalence of risk behavior among HIV-positive injection drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr. 2011; 56(5):e133-5. DOI: 10.1097/qai.0b013e31820bb1e5. View

15.

Pollini R, Gallardo M, Hasan S, Minuto J, Lozada R, Vera A . High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. Int J Infect Dis. 2010; 14 Suppl 3:e117-22. PMC: 2917477. DOI: 10.1016/j.ijid.2010.02.2238. View

16.

Hayashi K, Fairbairn N, Suwannawong P, Kaplan K, Wood E, Kerr T . Collective empowerment while creating knowledge: a description of a community-based participatory research project with drug users in Bangkok, Thailand. Subst Use Misuse. 2012; 47(5):502-10. DOI: 10.3109/10826084.2012.644110. View

17.

Hankins C . Changes in patterns of risk. AIDS Care. 1998; 10 Suppl 2:S147-53. DOI: 10.1080/09540129850124253. View

18.

McCoy C, Metsch L, Chitwood D, Miles C . Drug use and barriers to use of health care services. Subst Use Misuse. 2001; 36(6-7):789-806. DOI: 10.1081/ja-100104091. View

19.

Hayashi K, Wood E, Wiebe L, Qi J, Kerr T . An external evaluation of a peer-run outreach-based syringe exchange in Vancouver, Canada. Int J Drug Policy. 2010; 21(5):418-21. PMC: 2896564. DOI: 10.1016/j.drugpo.2010.03.002. View

20.

Mathers B, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee S . Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008; 372(9651):1733-45. DOI: 10.1016/S0140-6736(08)61311-2. View